The Division of Rheumatology and Clinical Immunogenetics focuses its educational, research and patient care efforts on the diagnosis and treatment of rheumatic diseases.

Diseases treated include: Rheumatoid arthritis, systemic lupus erythematosus, scleroderma, eosinophilic fasciitis, Sjögren’s syndrome, polymyositis and dermatomyositis, overlap syndromes including mixed connective tissue disease, polymyalgia rheumatica, relapsing polychondritis, relapsing panniculitis, erythema nodosum, adult-onset Still’s disease, primary antiphospholipid antibody syndrome, undifferentiated connective tissue disease, ankylosing spondylitis, reactive arthritis, psoriatic arthritis, inflammatory bowel disease-associated arthritis, arthritis associated with acne and other skin diseases, SAPHO syndrome, and undifferentiated spondyloarthropathies, temporal arteritis, Takayasu’s arteritis, polyarteritis nodosa and systemic necrotizing vasculitis overlaps, allergic granulomatosis of Churg-Strauss, Wegener’s granulomatosis and other ANCA-associated diseases, Behcet’s disease, hypersensitivity and small vessel angiitis, cryoglobulinemia, infectious and crystalline (such as gout and pseudogout) arthritides, osteoarthritis and nonarticular/regional musculoskeletal or “soft tissue” disorders.

All patients are evaluated by one of the faculty rheumatologists. Treatment modalities include anti-rheumatic medications, soft tissue and joint injections, and physical therapy. There is also a weekly Scleroderma Clinic headed by Dr. Mayes, as well as a Spondyloarthritis Clinic and a Lupus Clinic headed by Dr. Reveille and a Vasculitis clinic headed by Dr. Tan.